Complementary and alternative medicines in irritable bowel syndrome: an integrative view
- PMID: 24574705
- PMCID: PMC3923011
- DOI: 10.3748/wjg.v20.i2.346
Complementary and alternative medicines in irritable bowel syndrome: an integrative view
Abstract
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder with a high incidence in the general population. The diagnosis of IBS is mainly based on exclusion of other intestinal conditions through the absence of inflammatory markers and specific antigens. The current pharmacological treatment approaches available focus on reducing symptom severity while often limiting quality of life because of significant side effects. This has led to an effectiveness gap for IBS patients that seek further relief to increase their quality of life. Complementary and alternative medicines (CAM) have been associated with a higher degree of symptom management and quality of life in IBS patients. Over the past decade, a number of important clinical trials have shown that specific herbal therapies (peppermint oil and Iberogast(®)), hypnotherapy, cognitive behavior therapy, acupuncture, and yoga present with improved treatment outcomes in IBS patients. We propose an integrative approach to treating the diverse symptoms of IBS by combining the benefits of and need for pharmacotherapy with known CAM therapies to provide IBS patients with the best treatment outcome achievable. Initial steps in this direction are already being considered with an increasing number of practitioners recommending CAM therapies to their patients if pharmacotherapy alone does not alleviate symptoms sufficiently.
Keywords: Cognitive behavioral therapy; Complementary and alternative medicine; Herbal therapy; Hypnotherapy; Irritable bowel syndrome; Peppermint.
Figures
Similar articles
-
Complementary and alternative medicine for treatment of irritable bowel syndrome.Can Fam Physician. 2009 Feb;55(2):143-8. Can Fam Physician. 2009. PMID: 19221071 Free PMC article. Review.
-
Complementary and alternative medicine for the irritable bowel syndrome.Gastroenterol Clin North Am. 2011 Mar;40(1):245-53. doi: 10.1016/j.gtc.2010.12.005. Gastroenterol Clin North Am. 2011. PMID: 21333910 Review.
-
Complementary and alternative medicine and mind-body therapies for treatment of irritable bowel syndrome in women.Womens Health (Lond). 2013 Nov;9(6):557-67. doi: 10.2217/whe.13.57. Womens Health (Lond). 2013. PMID: 24161308 Review.
-
Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.Complement Ther Med. 2020 Jan;48:102233. doi: 10.1016/j.ctim.2019.102233. Epub 2019 Nov 3. Complement Ther Med. 2020. PMID: 31987249
-
Treatment of irritable bowel syndrome using complementary and alternative medicine.J Chin Med Assoc. 2009 Jun;72(6):294-300. doi: 10.1016/S1726-4901(09)70375-2. J Chin Med Assoc. 2009. PMID: 19541564 Review.
Cited by
-
Aspects of the non-pharmacological treatment of irritable bowel syndrome.World J Gastroenterol. 2015 Oct 28;21(40):11439-49. doi: 10.3748/wjg.v21.i40.11439. World J Gastroenterol. 2015. PMID: 26523108 Free PMC article. Review.
-
Effectiveness of Group Emotional Schema Therapy on Psychological Distress, Severity and Frequency of Symptoms in Women with Irritable Bowel Syndrome.Adv Biomed Res. 2024 Jan 30;13:11. doi: 10.4103/abr.abr_85_22. eCollection 2024. Adv Biomed Res. 2024. PMID: 38525387 Free PMC article.
-
Treatment of irritable bowel syndrome in China: a review.World J Gastroenterol. 2015 Feb 28;21(8):2315-22. doi: 10.3748/wjg.v21.i8.2315. World J Gastroenterol. 2015. PMID: 25741137 Free PMC article. Review.
-
The usage of complementary and alternative medicine in gastrointestinal patients visiting the outpatients' department of a large tertiary care centre-views from Pakistan.Pan Afr Med J. 2016 Jul 15;24:247. doi: 10.11604/pamj.2016.24.247.9559. eCollection 2016. Pan Afr Med J. 2016. PMID: 27800102 Free PMC article.
-
Effects and Mechanisms of Acupuncture on Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review.Front Neurosci. 2022 Jul 15;16:918701. doi: 10.3389/fnins.2022.918701. eCollection 2022. Front Neurosci. 2022. PMID: 35911986 Free PMC article.
References
-
- Rey E, Talley NJ. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis. 2009;41:772–780. - PubMed
-
- Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009;104 Suppl 1:S1–S35. - PubMed
-
- Talley NJ, Zinsmeister AR, Melton LJ. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995;142:76–83. - PubMed
-
- Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci. 2002;47:225–235. - PubMed
-
- Lacy BE, Weiser K, Noddin L, Robertson DJ, Crowell MD, Parratt-Engstrom C, Grau MV. Irritable bowel syndrome: patients’ attitudes, concerns and level of knowledge. Aliment Pharmacol Ther. 2007;25:1329–1341. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous